Laser modification of the blood in vitro and in vivo in patients with Parkinson's disease

Bulletin of Experimental Biology and Medicine

Volumn 135, Issue 5, 2003, Pages 430-432

  Vitreshchak, T V ^a   Mikhailov, V V ^a   Piradov, M A ^a   Poleshchuk, V V ^a   Stvolinskii, S L ^a   Boldyrev, A A ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Cu Zn dependent superoxide dismutase; He Ne laser; Monoamine oxidase B; Parkinson's disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE;

ARTICLE; BLOOD CELL; CELL INTERACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HELIUM NEON LASER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW LEVEL LASER THERAPY; MITOCHONDRION; NEUROLOGIC DISEASE; PARKINSON DISEASE; REGULATORY MECHANISM; THROMBOCYTE;

BLOOD; BLOOD PLATELETS; CATALASE; HUMANS; LASERS; MITOCHONDRIA; MONOAMINE OXIDASE; PARKINSON DISEASE; SUPEROXIDE DISMUTASE;

EID: 0242300650     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024950922391     Document Type: Article

References (7)

1. T. V. Vitreshchak, V. V. Poleshchuk, I. A. Ivanova-Smolenskya, et al., Neirokhimiya, 19, No. 3, 213-218 (2002).
2. L. L. Goncharova, L. A. Pokrovskaya, I. N. Ushakova, and N. Yu. Mal'kova, Mezhdunar. Med. Obz., 2, No. 1, 15-19 (1994).
3. M. A. Pal'tsev and A. A. Ivanov, Cell-Cell Interaction [in Russian], Moscow (1995).
4. T. V. Chichuk, I. A. Strashkevich, and G. I. Klebanov, Vestn. RAMN, No. 2, 27-32 (1999).
5. A. D. Shalabodov and N. V. Guseva, Principles of Membrane Transport [in Russian], Tyumen' (2001).
6. Y. Agid, Neurology, 57, Suppl.3, 46-51 (2001).
7. C. W. Olanov, P. Jenner, N. A. Tatton, and W. G. Tatton, in: Parkinson's Disease and Movement Disorders, Eds. J. Jankovic and E. Tolosa, Baltimore (1998), pp. 67-103.